Crossmark

Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study

Crossref DOI link: https://doi.org/10.1007/s12032-023-02059-w

Published Online: 2023-06-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Manyi

Hao, Yue

Zhou, Huan

shi, Zheng

Si, Jinfei

Song, Zhengbo https://orcid.org/0000-0002-2226-0570
Funding

Funding for this research was provided by:

the Medical Scientific Research Foundation of Zhejiang Province (No.2022KY653)
License Information

Text and Data Mining valid from 2023-06-09

Version of Record valid from 2023-06-09
More Information

Article History

Received: 12 April 2023

Accepted: 20 May 2023

First Online: 9 June 2023

Declarations

:

: All authors declare no conflict of interest.

: Approval of the study protocol was obtained from Zhejiang Cancer Hospital Institutional Review Board Committee (approval number: IRB-2022–187). Individual consent for this retrospective analysis was waived.

: Not applicable.

: Individual consent for analysis was waived.

Document is current

Any future updates will be listed below